?? The IDEA Collider Podcast – Season 3 Coming Soon! Brought to you by IDEA Pharma, the IDEA Collider podcast explores how organizations gain a competitive edge through asymmetric learning—featuring thought leaders and experts who break down the systems and processes behind outperformance. Season 3 is launching soon! Subscribe on your favorite platform (Apple, Spotify, etc.) and follow SAI MedPartners LLC or IDEA Pharma | From R&D to RxD to stay updated on new episodes. ?? Listen here: https://lnkd.in/eQj4U3Y3
SAI MedPartners LLC
商务咨询服务
Reading，Pennsylvania 5,493 位关注者
#LifeSciences #Healthcare #Consulting
关于我们
We are a knowledge-led global consultancy providing high-quality strategic insights and analytics to the pharmaceutical and medical device industries. Our perspective is global with on-the-ground primary research capabilities in offices across the Americas, Europe, India and Asia. Our insights are informed and grounded with extensive healthcare industry experience and deep therapeutic area expertise. To set the highest standard-of-quality for strategy development in the pharmaceutical and biotechnology arenas – that’s been SAI’s mission – and passion – since our founding. Our staff possesses an extensive and unique combination of business, clinical and scientific expertise, developed through years of hands-on industry experience.
- 网站
-
https://www.sai-med.com
SAI MedPartners LLC的外部链接
- 所属行业
- 商务咨询服务
- 规模
- 201-500 人
- 总部
- Reading，Pennsylvania
- 类型
- 合营企业
- 创立
- 1978
- 领域
- Pharmaceuticals、Emerging BioPharma、Medical Devices、Biotechnology、Management Consultancy、Competitive Intelligence、Strategy、market research、Life Sciences、Business Development、Oncology、Rare Diseases、Cardiology、Neurology、Cell therapy、Gene Therapy、Immunology、Infectious Disease、Vaccines和Dermatology
地点
SAI MedPartners LLC员工
动态
-
Today, we recognize the incredible contributions of women in healthcare, life sciences, and beyond. At SAI MedPartners, we are proud to support and empower the talented women who drive innovation, insight, and impact every day. Let’s continue to champion equality, inclusion, and opportunities for all. #InternationalWomensDay #IWD2025 #AccelerateAction #SAIMedPartners
-
-
If you’re passionate about the latest trends and insights in Pharma R&D, make sure to check out the IDEA Pharma | From R&D to RxD monthly newsletter. Join thousands of industry leaders staying informed—sign up today!
Sign up to the monthly IDEA Pharma | From R&D to RxD Junkie Newsletter. For nearly 10 years we've produced a simple monthly email update on all things IDEA Pharma. Thousands of Pharma industry leaders are already in on it, are you? ?? Be the first to get our Innovation Index results. ?? Hear when new podcasts launch. ?? Peek under the hood at what we are working on. ?? Tap into Mike Rea's prolific writing and recording habits. ??? Unlock insights from our regular contributor CMO Alexander Gray. We've built one of the leading sources of new ideas on how to transform Pharma and Biotech R&D. Join us! https://lnkd.in/gJ6x9j8B
-
Innovation and value creation in pharma – a key discussion on the Cures & Capital Podcast We're excited to highlight this insightful conversation featuring Mike Rea, CEO of IDEA Pharma | From R&D to RxD, a division of SAI, as he delves into the future of innovation and value creation in the pharmaceutical industry. Watch the full episode in the links below! #Pharma #Innovation #DrugDevelopment #Healthcare #ValueCreation
????? New podcast episode - with our guest Mike Rea: ?? Why pharma struggles with innovation - and how to fix it ?? In this episode, we interview Mike Rea, CEO of IDEA Pharma | From R&D to RxD. He does not hold back his views on pharma's confusion over its innovation, and he has seen a lot over the years! There are many thoughtful topics for you in this episode: ?? Pharma's confusion over innovation ?? Earlier commercial engagement in drug R&D ?? Decision quality: Optionality & better questions ?? Ranking pharma companies by innovation impact ?? The power of small teams in drug R&D Follow Cures & Capital - PODCAST to stay updated on future episodes. ?? Leave a comment and join the discussion on how to improve value creation in biotech and pharma. This is a critical discussion. ?? Lastly, a simple piece of advice from Martin and Simon - your podcast hosts: Make sure that more R&D and commercial people have lunch together in the coming days ?? ?? Links to the episode ?? ?? YouTube - https://lnkd.in/djEHfJzP ?? Spotify - https://lnkd.in/dhSUrKZe ?? Apple Podcasts - https://lnkd.in/djcPSQYQ
-
-
At SAI MedPartners, we are proud to be a part of recognizing the importance of Rare Disease Day and raising awareness for the millions impacted by rare conditions. Our division, Fulcrum Research Group, is shining a light on the challenges and needs of the rare disease community, and we stand with them in this mission. #RareDiseaseDay #Awareness #LightUpForRare
Rare Disease Day may only be one day a year, but every day over 300 million people globally live with rare and ultra rare diseases. We are honored to spend a significant portion of our time working with clients dedicated to innovation in rare disease, and in addition to raising awareness on this important day, we also want to highlight and thank an organization that has touched many of our lives personally. Ronald McDonald House provides comfort, care and support for families with children who are sick around the world. We are proud to support them in their mission this year through a corporate donation from the SAI family (SAI MedPartners LLC, Fulcrum Research Group, PharmaForce International, IDEA Pharma | From R&D to RxD). Let’s Light Up for Rare and ensure every family has the support they need. #LightUpForRare #RareDiseaseDay #Awareness
-
At SAI MedPartners, we believe in raising awareness through action. This week, our teams came together to create Lite-Brite designs, each representing what #RareDiseaseDay means to us. From symbols of hope to powerful messages of support, these designs are a reflection of our commitment to the rare disease community. Join us as we #LightUpForRare!
-
-
This year, our teams at SAI MedPartners, Fulcrum Research Group, a division of SAI MedPartners, PharmaForce International, and IDEA Pharma | From R&D to RxD took a creative approach to raising awareness for the rare disease community. Inspired by Lite-Brite, we crafted vibrant designs to represent what Rare Disease Day means to us. As we approach Rare Disease Day on February 28th, we invite you to take a look at our creations and join us in shining a light on rare disease awareness! #LightUpForRare #RareDiseaseAwareness #SAIMedPartners
-
At SAI MedPartners, we thrive on strategic thinking that turns possibilities into realities. Explore this insightful piece by Mike Rea at IDEA Pharma, a division of SAI, on the impact of conditional thinking in R&D. #Strategy #Innovation #Pharma #Biotech #RDtoRxD
Which if am I thenning? Read the full piece by Mike Rea here https://lnkd.in/ehqeYpfv The concept of 'if, then' is the backbone of logical reasoning, a simple yet profound structure that mirrors the cause and effect our lives are built upon. Imagine it as a magical doorway in the realm of thought: if you step through one side with a condition, then you emerge on the other with a consequence.
-
Rare Disease Day is on February 28, 2025—a time to raise awareness and drive change. At SAI MedPartners, we support innovation in rare disease research to improve patient outcomes. Join us in spreading awareness. #RareDiseaseDay #HealthcareInnovation #SAIMedPartners
-
-
In the ever-evolving life sciences landscape, understanding the competitive environment is essential for making informed decisions. Our team delivers comprehensive intelligence to help you stay ahead. Our approach combines actionable primary intelligence from our extensive global networks of KOLs and industry sources, along with robust secondary research utilizing powerful global subscription databases. This blend provides a complete picture of the market, enabling you to anticipate challenges and seize opportunities. Whether it's assessing competitors' pipelines, monitoring therapy areas, or uncovering analogues, our insights chart a path toward the best possible outcomes—whether you're in the development phase or maximizing market share. Connect with us: https://ow.ly/ekBP50UAxgQ #PharmaIntelligence #CompetitiveAnalysis #DrugDevelopment #StrategicInsights #SAIMedPartners
-